Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-20-037365

Director acquired 8,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
DOBMEIER ERIC Director 2020-06-16 Grant or award +8,000 28,000 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
DOBMEIER ERIC Director 2020-06-16 Grant or award · Non-Qualified Stock Option (Right to Buy) +24,500 24,500 D: show line 2 in the form
Loading xslF345X03/doc4.xml…